US Patent 11529405 MDR
Patent 11529405 was granted and assigned to Janssen Pharmaceuticals on December, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11529405 MDR
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
